About Roger Perlmutter
Roger Perlmutter is a director at NGM Bio.
Form D filings also name Roger Perlmutter as CEO and director at Eikon Therapeutics.
Roger Perlmutter reports to the SEC as a director or officer of 5 public companies, including Eikon Therapeutics (EIKN), NGM Biopharmaceuticals (NGM) and Merck & Co. (MRK).
Roger Perlmutter first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Roger Perlmutter in the role, so the role may have started earlier or lasted longer.
NGM Bio Holdings, Inc.
Director
2024 – 2026 · South San Francisco, CA
Develops medicines for people with serious diseases through its subsidiary.
NI
NGM Biopharmaceuticals Inc.
Director
2021 – 2024 · Public company (NGM)
MI
Merck & Co., Inc.
Exe V-P & Pres, MRL
2013 – 2020 · Public company (MRK)
MI
Microbot Medical Inc.
Director
2006 – 2012 · Public company (MBOT)
AI
Amgen Inc.
EVP, Research & Development
2006 – 2012 · Public company (AMGN)
Key Colleagues at Startups
The people Roger Perlmutter works with at each company, as listed on that company's latest Form D.
NGM Bio Holdings, Inc. · Form D/A, Mar 27, 2026
Eikon Therapeutics, Inc. · Form D, Feb 28, 2025
RH
Robbie Huffines
Director
JW
Joshua Wolfe
Director
DB
Dror Berman
Director
JT
James Tananbaum
Director
LC
Leon Chen
Director
KF
Kenneth Frazier
Director
RW
Robin Washington
Director